about
Conspecific negative density dependence and forest diversity.Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical TrialPhylogenetic and chemotypic diversity of Periglandula species in eight new morning glory hosts (Convolvulaceae).Bending rules for animal propulsion.Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.Production of the alkaloid swainsonine by a fungal endosymbiont of the Ascomycete order Chaetothyriales in the host Ipomoea carnea.Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.Seasonality of the ctenophore Mnemiopsis leidyi in Narragansett Bay, Rhode IslandDifferential Allocation of Seed-Borne Ergot Alkaloids During Early Ontogeny of Morning Glories (Convolvulaceae)Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.ReplyANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical TrialsEarly Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol TRationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic RetinopathyEffect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialPHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trialReply
P50
Q34273314-31B87296-A5E4-4B3D-85E5-828782FACBACQ36103812-8DD3C0F4-6B58-443D-AA05-BC18E243597AQ38898606-4AFAF39B-59DC-453B-BE76-AC4037DB44E6Q46000878-C1D8667B-B25B-4DDC-A0B2-C11843D427A5Q46145320-56C14DBD-021B-402A-A419-E91CF115CB90Q46649714-E42A7E37-EA9C-4302-A283-8E576D0DFF0EQ47697867-FC2420EF-6CCF-4398-82BD-3D6EBA95ED84Q50215366-B22997FE-B53A-4412-A9A7-732AF836CDA7Q56490066-6A4F5E32-A67F-446F-BA43-8B80B505DFBDQ60556134-42A1C724-07EE-45DC-A943-FB58F6BA6F6BQ64928226-8F52E582-34DB-487F-81E6-CD2653CCD3FEQ89496249-82BAB402-EFD1-4FC8-A716-D196429742A2Q90371390-E2D05F17-65C4-4C2A-80B1-E9C1622508C8Q90754573-2995EC18-1E87-41E3-A045-5612B2A57B9DQ90872445-C8A14E33-57BB-4EA9-B406-8F98DE102A6FQ91626896-BCE25C58-78D8-43B8-A24E-9657E2B73AE0Q91932657-CCD311F2-0DBB-4C17-9686-4F8E31D7B550Q92958551-A9024BE0-72DD-4209-B422-C06E3F7BBD68Q95427202-AD899451-4E5A-4FF7-9C7D-ADC3AEA53F39
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wesley T. Beaulieu
@ast
Wesley T. Beaulieu
@en
Wesley T. Beaulieu
@es
Wesley T. Beaulieu
@nl
type
label
Wesley T. Beaulieu
@ast
Wesley T. Beaulieu
@en
Wesley T. Beaulieu
@es
Wesley T. Beaulieu
@nl
prefLabel
Wesley T. Beaulieu
@ast
Wesley T. Beaulieu
@en
Wesley T. Beaulieu
@es
Wesley T. Beaulieu
@nl
P106
P21
P31
P496
0000-0002-0082-1242